Real-World test for approved breast cancer drug seeks to confirm benefits
NCT ID NCT06495541
Summary
This study aims to observe how effective and safe the drug pyrotinib is for treating advanced HER2-positive breast cancer in a real-world setting. It will enroll 500 patients who are starting this treatment for the first time, following their progress as they receive care from their own doctors. The main goal is to see how long patients live without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.